Abstract

Oxford Global is proud to present its Biomarkers and Precision Medicine USA Congress 2016, 3-4 Oct 2016, Boston, USA. Our renowned congress will bring together over 250 attendees from pharmaceutical and biotechnology companies as well as academia. The 2 day exciting programme covers case studies from a range of therapeutic areas including, oncology, immune-oncology, cardiovascular diseases, metabolic diseases, autoimmune diseases, fibrotic disorders, diabetes and more in the pre-clinical and clinical arena. Do not miss out on the latest development sin companion diagnostics and precision medicine. Experts will also discuss presentations on NGS as a choice of diagnostics, microRNAs as a potential circulating biomarker of drug-induced liver injury and the potential of metabolomics profiling to understand disease process and therapy.